Patents by Inventor Sadao Yabushita

Sadao Yabushita has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 5372997
    Abstract: It has been found that aluminum, which is considered as to cause various diseases such as dialysis dementia, bone diseases, hypochromic anemia and Alzheimer's disease, would be eluted into a conventional albumin preparation preserved in a hard glass container, which increases the aluminum concentration of the preparation. According to the present invention, it has been found that the substitution of the conventional hard glass container with a soft glass container dealkalized by, for example, treatment with sulfurous acid gas or ammonium sulfate solution for preserving an albumin preparation can make it possible to prevent the elution of aluminum from the container, thus giving a highly safe albumin preparation which can be maintained with an extremely low aluminum concentration over a long period of time.
    Type: Grant
    Filed: May 28, 1993
    Date of Patent: December 13, 1994
    Assignee: The Green Cross Corporation
    Inventors: Masahiro Inoue, Hirokazu Ito, Shinji Tomioka, Sadao Yabushita, Koei Ikariya, Kohichi Furuta
  • Patent number: 4754019
    Abstract: High purity albumin can be recovered in high yield from human plasma protein solution containing albumin by heat-treatment of the solution to denature and precipitate non-albumin proteins in a combination of specific conditions such as protein concentration of the solution, pH, heating time and temperature, the concentration of precipitant ammonium sulfate.
    Type: Grant
    Filed: June 12, 1987
    Date of Patent: June 28, 1988
    Assignee: The Green Cross Corporation
    Inventors: Yoshihiko Gion, Yasuo Uehara, Minoru Inosaka, Sadao Yabushita
  • Patent number: 4168303
    Abstract: Freeze-drying of an aqueous solution of human native gamma globulin having an anticomplementary activity of 20 (C'H50) or less in the presence of 0.06 to 0.26 part by weight of a neutral inorganic salt for 1 part by weight of the gamma globulin gives an immunoactive lyophilized native gamma globulin preparation which has undergone neither increase in anticomplementary activity nor deterioration in antibody activity during the freeze-drying and is safe for use in intravenous administration.
    Type: Grant
    Filed: June 7, 1978
    Date of Patent: September 18, 1979
    Assignee: The Green Cross Corporation
    Inventors: Masayuki Nishida, Sadao Yabushita, Shigeru Fujita, Toshiyuki Saki